Log in to MyACC
Discover best practices and emerging science across practice-changing topics designed to support excellence in patient care. Join leading experts for interactive, case-based sessions that deliver the latest evidence on the safety and efficacy of new and evolving therapies. Build confidence in translating clinical insights into real-world practice and stay at the forefront of cardiovascular disease prevention.
Learn to implement current and emerging lipid guidelines into a high-functioning cardiometabolic clinic using modern risk assessment tools, biomarkers, and individualized treatment strategies.
Enhance your understanding of hypertriglyceridemia with practical strategies to identify risk, evaluate underlying causes, and apply current and emerging therapies.
This series is supported by independent educational grants from Amgen, Boehringer Ingelheim, Esperion, Ionis Pharmaceuticals, Merck Sharp & Dohme LLC, and Novartis.
